ZAc 8709.0
(0.02%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 206.22 Billion | 22.96 Billion | 199.81 Billion | 131.39 Billion | 147.7 Billion | 77.88 Billion |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | 206.22 Billion | 22.96 Billion | 199.81 Billion | 131.39 Billion | 147.7 Billion | 77.88 Billion |
Operating Expenses | 198.74 Billion | -6.95 Billion | -187.72 Billion | -125.72 Billion | -135.9 Billion | -61.08 Billion |
Selling, General and Administrative Expenses | 18.29 Billion | 35.49 Billion | 43.17 Billion | 42.2 Billion | 41.05 Billion | 31.7 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 180.45 Billion | -42.44 Billion | -230.89 Billion | -167.92 Billion | -176.95 Billion | -92.78 Billion |
Cost and Expenses | 198.74 Billion | 73.75 Billion | 182.31 Billion | 123.95 Billion | 133.13 Billion | 60.91 Billion |
Operating Income | -2.95 Billion | 16.01 Billion | 12.08 Billion | 5.67 Billion | 11.79 Billion | 16.8 Billion |
Interest Expense | 1.51 Billion | 1.12 Billion | 1.01 Billion | 1.05 Billion | 1.74 Billion | 1.01 Billion |
Income Tax Expense | 7.07 Billion | 3.02 Billion | 3.69 Billion | 3.8 Billion | 5.75 Billion | 4.16 Billion |
Earnings before Tax | 20.68 Billion | 38.6 Billion | 17.5 Billion | 7.43 Billion | 14.56 Billion | 16.96 Billion |
Net Income | 14.47 Billion | 35.58 Billion | 13.8 Billion | 2.86 Billion | 7.15 Billion | 11.62 Billion |
Earnings Per Share Basic | 7.03 | 17.37 | 6.70 | 1.39 | 3.46 | 5.65 |
Earnings Per Share Diluted | 6.93 | 17.12 | 6.61 | 1.37 | 3.42 | 5.60 |
Weighted Average Shares Outstanding | 2.06 Billion | 2.04 Billion | 2.06 Billion | 2.06 Billion | 2.06 Billion | 2.05 Billion |
Weighted Average Shares Outstanding (Diluted) | 2.08 Billion | 2.07 Billion | 2.08 Billion | 2.08 Billion | 2.09 Billion | 2.07 Billion |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | 0.10 | 0.77 | 0.07 | 0.06 | 0.10 | 0.23 |
Profit Margin | 0.07 | 1.55 | 0.07 | 0.02 | 0.05 | 0.15 |
EBITDA | 20.43 Billion | 15.16 Billion | 16.07 Billion | 6.15 Billion | 15.74 Billion | 16.56 Billion |
Earnings Before Tax Margin | -0.01 | 0.70 | 0.06 | 0.04 | 0.08 | 0.22 |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 96.79 Billion | 206.22 Billion | 97.79 Billion | 47.22 Billion | 108.42 Billion | 48.81 Billion |
Cost of Revenue | - | - | - | - | - | -3.53 Billion |
Gross Profit | 96.79 Billion | 206.22 Billion | 97.79 Billion | 47.22 Billion | 108.42 Billion | 52.35 Billion |
Operating Expenses | 44.73 Billion | 107.6 Billion | 50.1 Billion | 41 Billion | 64.89 Billion | 43.92 Billion |
Selling, General and Administrative Expenses | - | - | 5.43 Billion | 5.43 Billion | 3.17 Billion | 3.17 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -44.73 Billion | -107.6 Billion | -50.1 Billion | - | -64.89 Billion | - |
Cost and Expenses | -83.33 Billion | -186.89 Billion | -87.24 Billion | 41 Billion | -99.65 Billion | 43.92 Billion |
Operating Income | 1.98 Billion | 3.83 Billion | 19.19 Billion | 19.19 Billion | 27.92 Billion | 27.92 Billion |
Interest Expense | 818 Million | 1.51 Billion | 861 Million | - | 657 Million | - |
Income Tax Expense | 4.21 Billion | 7.07 Billion | 3.46 Billion | 1.73 Billion | 3.61 Billion | 1.8 Billion |
Earnings before Tax | 12.16 Billion | 17.72 Billion | 9.63 Billion | 5.78 Billion | 8.09 Billion | 4.55 Billion |
Net Income | 9.93 Billion | 14.47 Billion | 6.56 Billion | 3.33 Billion | 7.91 Billion | 2.46 Billion |
Earnings Per Share Basic | 4.78 | - | 3.18 | 1.58 | 3.89 | 1.19 |
Earnings Per Share Diluted | 4.71 | - | 3.10 | 1.58 | 3.83 | 1.19 |
Weighted Average Shares Outstanding | 2.07 Billion | 2.06 Billion | 2.06 Billion | 2.11 Billion | 2.03 Billion | 2.06 Billion |
Weighted Average Shares Outstanding (Diluted) | 2.1 Billion | 2.08 Billion | 2.11 Billion | 2.11 Billion | 2.06 Billion | 2.06 Billion |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.07 |
EBIT Margin | 0.03 | - | -0.14 | -0.30 | -0.22 | -0.48 |
Profit Margin | 0.10 | 0.07 | 0.07 | 0.07 | 0.07 | 0.05 |
EBITDA | 2.69 Billion | - | -14.13 Billion | -14.13 Billion | -23.65 Billion | -23.65 Billion |
Earnings Before Tax Margin | 0.02 | 0.02 | 0.20 | 0.41 | 0.26 | 0.57 |
YOGI
SGL
3577
3311
BORORENEW
BIOTEC